Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury
Author(s) -
Edith Hochhauser,
Eylon Lahat,
Maya Sultan,
Orit Pappo,
Maayan Waldman,
Yosef Sarne,
Asher Shainberg,
Mordechai Gutman,
Michal Safran,
Ziv Ben Ari
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000430165
Subject(s) - pharmacology , oxidative stress , reperfusion injury , medicine , liver injury , tunel assay , proinflammatory cytokine , ischemia , apoptosis , cannabinoid , endocrinology , chemistry , inflammation , receptor , biochemistry , immunohistochemistry
Ischemia/reperfusion (I/R) injury is the main cause of both primary graft dysfunction and primary non-function of liver allografts. Cannabinoids has been reported to attenuate myocardial, cerebral and hepatic I/R oxidative injury. Delta-9-tetrahydrocannabinol (THC), a cannabinoid agonist, is the active components of marijuana. In this study we examined the role of ultralow dose THC (0.002mg/kg) in the protection of livers from I/R injury. This extremely low dose of THC was previously found by us to protect the mice brain and heart from a variety of insults.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom